MedTech Dive January 22, 2024
DNA testing firm Natera could pay up to $52.5 million total, and plans to move Invitae’s customers to its own tests.
Dive Brief:
- Medical genetics firm Invitae sold its reproductive health assets to Natera for up to $52.5 million, the companies announced on Monday.
- Natera paid $10 million upfront. The agreement also includes up to $42.5 million in milestone payments and litigation credits.
- Invitae is selling the segment as it faces liquidity concerns. The sale is expected to reduce its operating expenses by $44 million, excluding one-time severance payments.
Dive Insight:
Invitae raised doubts about its ability to continue as a going concern in the third quarter. As of Sept. 30, the San Francisco-based company had...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices